Infrared thermal imaging (IRI) is a contact-less technology able to monitor human skin
temperature for biomedical applications and in real-life contexts. Its capacity to detect fever …

The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current
or past history of cancer facing disparate consequences at every stage of the cancer …

Immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI)
therapy may vary substantially in their clinical presentation, including natural history …

Patients with cancer generally have a higher risk of adverse outcomes from COVID-19, with
higher age, male sex, poor performance status, cancer type, and uncontrolled malignant …

The immune checkpoints associated with the CTLA-4 and PD-1 pathways are critical
modulators of immune activation. These pathways dampen the immune response by …

Since the outbreak of COVID-19, several published reports of increased psychological
problems turned the attention towards this field and ignited controversies surrounding it. Our …

Immunocheckpoint inhibitors (ICIs) have altered the treatment landscape of a wide range of
malignancies, including non–small cell lung cancer (NSCLC). This class of agents inhibits …

BACKGROUND Given the several radiological features shared by coronavirus disease 2019
pneumonia and other infective or non-infective diseases with lung involvement, the …

An early meta-analysis of 16 studies of patients with COVID-19 receiving systemic cancer
therapy, found an increased risk of death in those receiving chemotherapy within the past …

As the coronavirus disease 2019 (COVID-19) pandemic continues, cancer patients were
found to be vulnerable and to have difficulty receiving routine care. We analyzed patients …